mu opioid receptor drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (12)
Papers in which this entity is mentioned.
- Sex/gender differences in brain function and structure in alcohol use: A narrative review of neuroimaging findings over the last 10 years. (2021)
- Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling. (2020)
- Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018)
- Genome-wide association study of nicotine dependence in American populations: identification of novel risk loci in both African-Americans and European-Americans. (2015)
- Pharmacogenetics of OPRM1. (2014)
- Circadian genes, the stress axis, and alcoholism. (2012)
- Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. (2012)
- Regulation of cancer progression by β-endorphin neuron. (2012)
- The genetics of the opioid system and specific drug addictions. (2012)
- Pharmacological treatment of cannabis dependence. (2011)
- Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. (2009)
- Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. (1996)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| mu opioid receptor | drug | 7 | 8 |
| mu-opioid receptor | drug | 4 | 4 |
| μ-opioid receptor | drug | 3 | 3 |